mergers & acquisitions Precision for Medicine's QuartzBio Acquires Genomic Data Analytics Firm SolveBio QuartzBio expects SolveBio's genomics and clinical data analytics technology to accelerate biomarker discovery in pursuit of precision therapies. Inscripta Acquires Infinome Biosciences, Sestina Bio The acquisitions suggest that Inscripta has shifted its focus to biomanufacturing following dozens of layoffs across two site closures in December. Agbio Gene Editing Firm Cibus to Merge With Plant Synbio Company Calyxt The newly merged company will retain the Cibus name and trade on the Nasdaq Capital Market, where Calyxt is currently listed. Pierian, Seven Bridges, UgenTec Acquired, Merged to Become Velsera The three firms were acquired by investment fund Summa Equity and merged to form a new Boston-headquartered company. Scipher Medicine Buys Software Firm CrossBridge Precision immunology firm Scipher said the acquisition of Philadelphia-based CrossBridge is intended to strengthen its data management and analytics capabilities. Jan 5, 2023 Macroeconomic Worries Lead to More Subdued Omics, MDx M&A Activity in 2022 Premium Jan 4, 2023 Moderna to Acquire Japan's OriCiro Genomics for $85M Jan 4, 2023 Agilent Technologies Acquires NGS Target Enrichment Firm Avida Biomed Dec 20, 2022 Invitae Sells Archer NGS Research Assays to Integrated DNA Technologies for $48M Dec 5, 2022 European Commission Outlines Intended Restorative Measures for Blocked Illumina-Grail Deal Nov 29, 2022 Bionano Genomics to Acquire Purigen Biosystems for up to $64M Nov 22, 2022 Biocare Medical Acquires Empire Genomics Nov 3, 2022 Werfen to Acquire Immucor for $2B Nov 2, 2022 Myriad Genetics Sees Growth Opportunities on Other Side of Economic Headwinds Premium Nov 1, 2022 Myriad Genetics Acquires Gateway Genomics as Q3 Revenues Drop 7 Percent, Miss Estimates Oct 31, 2022 Thermo Fisher Scientific to Acquire The Binding Site Group for £2.25B in Cash Oct 27, 2022 Cardio Diagnostics Prepares for New Test Launches Following IPO Premium Oct 18, 2022 Patients Choice Laboratories Acquires Texas-Based Infectious Disease MDx Lab Oct 17, 2022 Clinical Microbiomics Acquires Metabolomics Firm MS-Omics Oct 14, 2022 DiaCarta to go Public Through SPAC Merger Oct 10, 2022 Bio-Rad, Qiagen Shares Drop on Report of Possible Merger Oct 6, 2022 Pluristyx, Pancella, Implant Therapeutics Agree to Merge Oct 4, 2022 Ginkgo Bioworks Acquires Circularis, Altar Sep 26, 2022 BioIVT Acquires Biospecimen Firm Fidelis Research Sep 16, 2022 MDxHealth Plans One-Stop Shop for Prostate Cancer Dx With Acquisition of Oncotype GPS Assay Premium Load More Breaking News New Products Posted to GenomeWeb: Qiagen, Thermo Fisher, Bionano Genomics, BillionToOne, More People in the News at Illumina Ventures, Element Biosciences, Epigenomics, Exagen, More Genomic Approaches Boost Rare Disease Diagnoses in Middle Eastern Patient Population GeneDx to Raise $150M in Public and Direct Stock Offerings In Brief This Week: T2 Biosystems, Novacyt, OpGen, Dante Genomics, Nautilus Biotechnology, More The Scan Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups. Genome-Wide Analysis Sheds Light on Genetics of ADHD A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder. MicroRNA Cotargeting Linked to Lupus A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus. Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.